We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.98%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$480M
AUM Growth
+$96.7M
(+25%)
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
17.13%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
645
New
258
Increased
78
Reduced
78
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.7M |
| 2 |
Nasdaq
NDAQ
|
+$5.95M |
| 3 |
Fidelity National Information Services
FIS
|
+$5.66M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$5.09M |
| 5 |
Novartis
NVS
|
+$5.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$5.84M |
| 2 |
ExxonMobil
XOM
|
+$5M |
| 3 |
CrowdStrike
CRWD
|
+$4.96M |
| 4 |
British American Tobacco
BTI
|
+$4.57M |
| 5 |
Blackstone
BX
|
+$4.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 8.55% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Warner Bros
WBD
$65.6B
| $906K | 0.19% |
+59,987
| New | +$854K |
|
152
Hewlett Packard
HPE
$65.1B
| $883K | 0.18% |
55,417
+8,333
| +18% | +$131K |
|
153
Amylyx Pharmaceuticals
AMLX
$2.19B
| $882K | 0.18% |
30,053
+15,115
| +101% | +$525K |
|
154
Pultegroup
PHM
$24.3B
| $875K | 0.18% |
+15,019
| New | +$811K |
|
155
Sherwin-Williams
SHW
$84.9B
| $870K | 0.18% |
+3,869
| New | +$885K |
|
156
Unilever
UL
$138B
| $870K | 0.18% |
14,884
-14,495
| -49% | -$824K |
|
157
Insulet
PODD
$11.7B
| $858K | 0.18% |
+2,689
| New | +$797K |
|
|
AQUA
158
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $855K | 0.18% |
+17,192
| New | +$803K |
|
159
Transocean
RIG
$5.7B
| $839K | 0.17% |
+131,996
| New | +$848K |
|
160
Hims & Hers Health
HIMS
$7.05B
| $839K | 0.17% |
+84,619
| New | +$742K |
|
161
Clorox
CLX
$11.8B
| $832K | 0.17% |
5,256
-3,132
| -37% | -$470K |
|
162
Paylocity
PCTY
$7.5B
| $827K | 0.17% |
+4,160
| New | +$819K |
|
163
Dell
DELL
$272B
| $825K | 0.17% |
+20,522
| New | +$827K |
|
164
Wolfspeed
WOLF
$1.29B
| $821K | 0.17% |
12,637
+2,875
| +29% | +$210K |
|
165
Blackrock
BLK
$172B
| $813K | 0.17% |
+1,215
| New | +$856K |
|
166
Brown & Brown
BRO
$24B
| $805K | 0.17% |
14,025
+5,759
| +70% | +$331K |
|
167
Emerson Electric
EMR
$85.3B
| $801K | 0.17% |
+9,190
| New | +$803K |
|
168
Pacific Biosciences
PACB
$447M
| $794K | 0.17% |
+68,551
| New | +$682K |
|
|
SPLK
169
DELISTED
Splunk Inc
SPLK
| $793K | 0.17% |
+8,273
| New | +$793K |
|
170
Albemarle
ALB
$14B
| $792K | 0.17% |
+3,585
| New | +$883K |
|
171
Bank of America
BAC
$434B
| $786K | 0.16% |
27,499
-44,598
| -62% | -$1.47M |
|
172
Waters Corp
WAT
$36.8B
| $777K | 0.16% |
+2,511
| New | +$812K |
|
173
Ball Corp
BALL
$17.3B
| $773K | 0.16% |
14,020
+8,206
| +141% | +$456K |
|
174
Cameco
CCJ
$38.8B
| $770K | 0.16% |
+29,413
| New | +$777K |
|
175
AutoZone
AZO
$49B
| $764K | 0.16% |
311
+132
| +74% | +$322K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Seven Eight Capital held 645 positions worth $480M, up 25% from $383M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Seven Eight Capital deployed $82.2M of net new capital in Q1 2023, opening 258 new positions and adding to 78 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $5.84M trimmed.
- Seven Eight Capital's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
- Seven Eight Capital added most to BioMarin Pharmaceuticals in Q1 2023, an estimated $5.09M increase.
- Seven Eight Capital's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $5.84M.
- Seven Eight Capital fully exited ExxonMobil in Q1 2023, selling an estimated $5M.
- Seven Eight Capital's ten largest holdings make up 20% of its $480M portfolio in Q1 2023.
- Seven Eight Capital opened 258 new positions and closed 231 in Q1 2023.
- Seven Eight Capital's portfolio value rose 25% quarter-over-quarter to $480M.
Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.